| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of SMARCA2 mRNA" | 26377693 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of SMARCA2 mRNA" | 19114083 |
| C016403 | 2,4-dinitrotoluene | "2,4-dinitrotoluene affects the expression of SMARCA2 mRNA" | 21346803 |
| C023514 | 2,6-dinitrotoluene | "2,6-dinitrotoluene results in increased expression of SMARCA2 mRNA" | 20406850 |
| C028451 | 3,4,3',4'-tetrachlorobiphenyl | "3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SMARCA2 mRNA]" | 19467301 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C035207 | 4-amino-2,6-dinitrotoluene | "4-amino-2,6-dinitrotoluene affects the expression of SMARCA2 mRNA" | 21346803 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of SMARCA2 mRNA | 21420995 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of SMARCA2 mRNA | 22230336 |
| D000082 | Acetaminophen | Acetaminophen affects the expression of SMARCA2 mRNA | 17562736 |
| D020106 | Acrylamide | Acrylamide results in decreased expression of SMARCA2 mRNA | 28959563 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone promotes the reaction [AR protein binds to SMARCA2 protein] | 18487222 |
| D013196 | Dihydrotestosterone | Dihydrotestosterone promotes the reaction [SMARCA2 protein binds to KLK3 promoter] | 18487222 |
| D000535 | Aluminum | [APP protein modified form binds to Aluminum] which results in increased expression of SMARCA2 mRNA | 21298039 |
| D018501 | Antirheumatic Agents | Antirheumatic Agents results in increased expression of SMARCA2 mRNA | 24449571 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of SMARCA2 mRNA | 20458559 |
| D001280 | Atrazine | Atrazine results in decreased expression of SMARCA2 mRNA | 25929836 |
| C487081 | belinostat | belinostat results in increased expression of SMARCA2 mRNA | 26272509 |
| C487081 | belinostat | "[NOG protein co-treated with belinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of SMARCA2 mRNA | 20106945|2163298 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of SMARCA2 mRNA | 20504355 |
| C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SMARCA2 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of SMARCA2 mRNA | 26364221 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A affects the expression of SMARCA2 mRNA | 25181051 |
| C006780 | bisphenol A | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMARCA2 promoter | 23359474 |
| C006780 | bisphenol A | bisphenol A results in increased methylation of SMARCA2 gene | 28505145 |
| C000611646 | bisphenol F | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mRNA | 28628672 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in decreased expression of SMARCA2 mRNA | 15336504 |
| D019256 | Cadmium Chloride | Cadmium Chloride results in decreased expression of SMARCA2 mRNA | 18560533 |
| D020245 | p-Chloromercuribenzoic Acid | "[NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| D020245 | p-Chloromercuribenzoic Acid | p-Chloromercuribenzoic Acid results in increased expression of SMARCA2 mRNA | 26272509 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SMARCA2 mRNA | 20938992 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SMARCA2 | 20938992 |
| D002794 | Choline | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SMARCA2 gene | 20938992 |
| D002994 | Clofibrate | Clofibrate results in decreased expression of SMARCA2 mRNA | 16081524 |
| D003042 | Cocaine | Cocaine results in increased expression of SMARCA2 mRNA | 17898221 |
| D003300 | Copper | [Thiosemicarbazones binds to Copper] which results in increased expression of SMARCA2 protein | 20931265 |
| D019327 | Copper Sulfate | Copper Sulfate results in increased expression of SMARCA2 mRNA | 19549813 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of SMARCA2 mRNA | 25562108 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of SMARCA2 mRNA | 19770486 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of SMARCA2 mRNA | 21865292 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in increased expression of SMARCA2 mRNA | 23640034 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [RX3 gene mutant form affects the expression of SMARCA2 mRNA] | 27941970 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SMARCA2 mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mRNA | 28628672 |
| D003993 | Dibutyl Phthalate | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMARCA2 promoter | 23359474 |
| D004041 | Dietary Fats | "3,4,3',4'-tetrachlorobiphenyl inhibits the reaction [Dietary Fats results in increased expression of SMARCA2 mRNA]" | 19467301 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of SMARCA2 mRNA | 19030233|1946730 |
| D004041 | Dietary Fats | rimonabant inhibits the reaction [Dietary Fats results in increased expression of SMARCA2 mRNA] | 19030233 |
| D004051 | Diethylhexyl Phthalate | [bisphenol A co-treated with Diethylhexyl Phthalate co-treated with Dibutyl Phthalate] affects the methylation of SMARCA2 promoter | 23359474 |
| D011397 | Promegestone | SMARCA2 protein affects the reaction [Promegestone results in increased expression of FOS mRNA] | 19609353 |
| D011397 | Promegestone | SMARCA2 protein affects the reaction [Promegestone results in increased expression of MYC mRNA] | 19609353 |
| C118739 | entinostat | entinostat results in increased expression of SMARCA2 mRNA | 26272509|2718838 |
| C118739 | entinostat | "[NOG protein co-treated with entinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C045651 | epigallocatechin gallate | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMARCA2 mRNA | 22079256 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of SMARCA2 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCA2 mRNA | 17942748 |
| D005485 | Flutamide | Flutamide results in decreased expression of SMARCA2 mRNA | 24136188 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SMARCA2 mRNA | 20938992 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SMARCA2 | 20938992 |
| D005492 | Folic Acid | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SMARCA2 gene | 20938992 |
| C001277 | geldanamycin | geldanamycin results in increased expression of SMARCA2 mRNA | 26705709 |
| D019833 | Genistein | Genistein affects the expression of SMARCA2 mRNA | 18214933 |
| D005897 | Glafenine | Glafenine results in decreased expression of SMARCA2 mRNA | 24136188 |
| C029424 | hydrazine | hydrazine results in increased expression of SMARCA2 mRNA | 15282401 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SMARCA2 mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mRNA | 28628672 |
| D015759 | Ionomycin | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of SMARCA2 mRNA | 25613284 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in increased expression of SMARCA2 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in increased expression of SMARCA2 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of SMARCA2 mRNA | 28628672 |
| D007854 | Lead | Lead affects the expression of SMARCA2 mRNA | 28903495 |
| C042720 | mercuric bromide | mercuric bromide results in increased expression of SMARCA2 mRNA | 26272509 |
| C042720 | mercuric bromide | "[NOG protein co-treated with mercuric bromide co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased expression of SMARCA2 mRNA | 20938992 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of and results in decreased expression of SMARCA2 | 20938992 |
| D008715 | Methionine | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of SMARCA2 gene | 20938992 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in increased expression of SMARCA2 mRNA | 28001369 |
| D008741 | Methyl Methanesulfonate | Methyl Methanesulfonate results in decreased expression of SMARCA2 mRNA | 26011545 |
| C523799 | MRK 003 | MRK 003 results in decreased expression of SMARCA2 mRNA | 21169257 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog results in decreased expression of SMARCA2 mRNA" | 25554681|2562005 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of SMARCA2 mRNA" | 25554681|2562005 |
| D009532 | Nickel | Nickel results in decreased expression of SMARCA2 mRNA | 25583101 |
| D009532 | Nickel | Nickel results in decreased expression of SMARCA2 mRNA | 24084258 |
| C029938 | nickel sulfate | nickel sulfate results in decreased expression of SMARCA2 mRNA | 22714537 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of SMARCA2 mRNA | 24205000 |
| C496932 | panobinostat | "[NOG protein co-treated with panobinostat co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C496932 | panobinostat | panobinostat results in increased expression of SMARCA2 mRNA | 26272509 |
| D010416 | Pentachlorophenol | Pentachlorophenol results in increased expression of SMARCA2 mRNA | 24642059 |
| D010634 | Phenobarbital | Phenobarbital affects the expression of SMARCA2 mRNA | 23091169 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in increased expression of SMARCA2 mRNA | 26272509 |
| C006253 | pirinixic acid | pirinixic acid results in decreased expression of SMARCA2 mRNA | 18445702|2381119 |
| C027373 | potassium chromate(VI) | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of SMARCA2 mRNA | 22079256 |
| C027373 | potassium chromate(VI) | potassium chromate(VI) results in decreased expression of SMARCA2 mRNA | 22079256 |
| C089032 | rimonabant | rimonabant inhibits the reaction [Dietary Fats results in increased expression of SMARCA2 mRNA] | 19030233 |
| C513635 | S-2-pentyl-4-pentynoic hydroxamic acid | S-2-pentyl-4-pentynoic hydroxamic acid results in increased expression of SMARCA2 mRNA | 21427059 |
| D012822 | Silicon Dioxide | Silicon Dioxide analog results in decreased expression of SMARCA2 mRNA | 25895662 |
| C017947 | sodium arsenite | sodium arsenite affects the expression of SMARCA2 mRNA | 29319823 |
| C016104 | sodium bichromate | sodium bichromate results in decreased expression of SMARCA2 mRNA | 25993096 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of SMARCA2 mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of SMARCA2 mRNA | 15328365|1977048 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of SMARCA2 mRNA | 22298810 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of SMARCA2 mRNA | 21215274 |
| D013755 | Tetradecanoylphorbol Acetate | [Tetradecanoylphorbol Acetate co-treated with Ionomycin] results in decreased expression of SMARCA2 mRNA | 25613284 |
| D013882 | Thiosemicarbazones | [Thiosemicarbazones binds to Copper] which results in increased expression of SMARCA2 protein | 20931265 |
| C009495 | titanium dioxide | titanium dioxide results in decreased expression of SMARCA2 mRNA | 27760801 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of SMARCA2 mRNA | 23557971 |
| D014212 | Tretinoin | Tretinoin results in increased expression of SMARCA2 mRNA | 17218384|2193413 |
| D014212 | Tretinoin | Tretinoin results in increased expression of SMARCA2 mRNA | 16604517 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased methylation of SMARCA2 gene | 27618143 |
| C012589 | trichostatin A | "[NOG protein co-treated with trichostatin A co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| C012589 | trichostatin A | trichostatin A results in increased expression of SMARCA2 mRNA | 24935251|2627250 |
| D014520 | Urethane | Urethane results in increased expression of SMARCA2 mRNA | 28818685 |
| D014635 | Valproic Acid | "[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of SMARCA2 mRNA" | 27188386 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of SMARCA2 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of SMARCA2 mRNA | 19101580|2317975 |
| D014635 | Valproic Acid | Valproic Acid results in increased expression of SMARCA2 mRNA | 21427059 |
| D001335 | Vehicle Emissions | Vehicle Emissions affects the methylation of SMARCA2 gene | 25560391 |
| C025643 | vinclozolin | vinclozolin affects the expression of SMARCA2 mRNA | 19015723 |
| C025643 | vinclozolin | vinclozolin results in increased expression of SMARCA2 mRNA | 18042343 |
| C111237 | vorinostat | vorinostat results in increased expression of SMARCA2 mRNA | 27188386 |